FAM124A: A Protein Interaction and Drug Target (G220108)

Target Name: FAM124A

NCBI ID: G220108

FAM124A

FAM124A: A Protein Interaction and Drug Target

FAM124A (F124A_HUMAN) is a protein that is expressed in various tissues of the human body, including the brain, heart, and liver. It is a member of the FAM124 family of proteins, which are known for their role in cell signaling and inflammation.

One of the unique features of FAM124A is its ability to interact with various signaling pathways, including the TGF-β pathway. This pathway is involved in many cellular processes, including cell growth, differentiation, and inflammation. FAM124A has been shown to play a role in regulating the activity of the TGF-β pathway, which is important for the development and maintenance of tissues and organs.

FAM124A has also been shown to interact with the protein FBN1 (fibrinogen beta-nucleotide). FBN1 is a protein that is involved in the production of fibrin, a protein that is involved in blood clotting. FAM124A has been shown to regulate the activity of FBN1, which is important for the formation of functional blood clots.

In addition to its role in cell signaling and inflammation, FAM124A has also been shown to play a role in the development and progression of certain diseases. For example, studies have shown that FAM124A is expressed in the brains of individuals with Alzheimer's disease, a condition characterized by the progressive loss of brain cells. Additionally, FAM124A has been shown to be involved in the development of certain cancers, including breast and colorectal cancer.

Given its role in cell signaling and inflammation, as well as its involvement in the development and progression of certain diseases, FAM124A is a promising drug target. Researchers are currently working to develop small molecules that can inhibit the activity of FAM124A and prevent its progression to certain diseases. These small molecules may be used to treat a variety of conditions, including Alzheimer's disease, cancer, and other inflammatory conditions.

In conclusion, FAM124A (F124A_HUMAN) is a protein that is expressed in various tissues of the human body and plays a role in cell signaling and inflammation. Its ability to interact with various signaling pathways and its involvement in the development and progression of certain diseases make it an attractive drug target. Researchers are currently working to develop small molecules that can inhibit the activity of FAM124A and prevent its progression to certain diseases. These small molecules may be used to treat a variety of conditions, including Alzheimer's disease, cancer, and other inflammatory conditions.

Protein Name: Family With Sequence Similarity 124 Member A

The "FAM124A Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about FAM124A comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets